All asymptomatic women aged 50 to 74 years at an average risk for breast cancer should receive biennial screening mammography, new ACP guidance published in Annals of Internal Medicine states. Carolyn ...

Epicutis®, the professional skincare brand powered by patented biotechnology from Signum Biosciences, today announced the launch of Hydrobiome Serum ? a next-generation formulation that redefines how ...

Sensible’ recommendations support biennial screening from age 50 to 74, with individualized decision-making for women below ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

Commvault, a leader in unified resilience at enterprise scale, announced new and forthcoming AI capabilities that help organizations confidently adopt AI while maintaining control over data, agents, ...